Optimal dosing of medications

Journal of Family Practice

Volumn 52, Issue 3 SUPPL., 2003, Pages 22-25

  Maguire, Gerald A ^a   Phillips, Geoffrey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LITHIUM; OLANZAPINE; VALPROIC ACID; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; PIRENZEPINE; TRANQUILIZER;

BIPOLAR DISORDER; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MANIA; REVIEW; ACUTE DISEASE; AFFECT; CHRONIC DISEASE; DRUG ADMINISTRATION; DRUG EFFECT; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ACUTE DISEASE; AFFECT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; HUMANS; LITHIUM COMPOUNDS; PIRENZEPINE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0037359860     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Prien RF, Caffey EM, Klett CJ. Relationship between serum lithium level and clinical response in acute mania treated with lithium. Br J Psychiatry 1971;120:409-14.
2. Stokes PE, Koesis JH, Arcuni OJ. Relationship of lithium chloride dose to treatment response in mania. Arch Gen Psychiatry 1976;33:1080-4.
3. Coppen A, Abou-Saleh M, Millu P, Wood K. Decreasing lithium chloride dosage reduces morbidity and side effects during prophylaxis. J Affect Disord 1983;5(4):353-62.
4. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-93.
5. Keller MB, Lavori PW, Kane JM, et al. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1992;49:371-6.
6. Srisuarapanont M, Yatham LN, Zis AP. Treatment of acute bipolar depression: a review of the literature. Can J Psychiatry 1995;40(9):533-44.
7. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. Clin Psychopharmacol 1996;16(2 suppl 1):32S-47S.
8. Fieve RR, Adler LA, Allen MH, et al. Lithium as a mood stabilizer: fifty years later (abstract). Philadelphia: American Psychiatric Association annual meeting, 2002.
9. Keck PE, Jr., McElroy SL, Tugrul KC, et al. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-8.
10. Hirschfeld RM, Allen MH, McElvoy JP, Keck PE, Jr., Russell JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 1999;60(12):815-8.
11. Tohen MF, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olazapine HGEH Study Group. Am J Psychiatry 19991;156(5):702-9.
12. Tohen MF, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000;57:841-9.
13. Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL. Effectiveness of rapid initial dose escalation of up to 40 mg per day of oral olanzapine in acute agitation. J Clin Psychopharmacol 2003 (in press).
14. Tohen MF, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59(1):62-9.
15. Volavka J, Czobor P, Sheitman B, et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 2002;159:255-62.